Lebwohl, M. G.; Mehta, N. N.; Gottlieb, A. B.; Mendelsohn, A. M. Tildrakizumab Efficacy by Metabolic Syndrome Status in Psoriasis: Post Hoc Analysis of 3-Year Data from the Phase 3 Resurface 1 And Resurface 2 Studies. J of Skin 2020, 4, s42.